COMMUNIQUÉS West-GlobeNewswire

HEXO Corp. announces acquisition of Securities of Newstrike Brands Ltd.
28/05/2019
TORONTO, May 28, 2019 (GLOBE NEWSWIRE) -- On May 24, 2019, HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) and Newstrike Brands Ltd. (“ Newstrike ”) announced that they completed the previously announced [...]
HEXO Corp annonce l’acquisition des titres de Newstrike Brands Ltd.
28/05/2019
TORONTO, 28 mai 2019 (GLOBE NEWSWIRE) -- Le 24 mai 2019, HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE-A: HEXO) et Newstrike Brands Ltd. (« Newstrike ») ont annoncé la conclusion de l’arrangement précédemment [...]
Atara Biotherapeutics Appoints Pascal Touchon President, Chief Executive Officer and Member of the Board of Directors
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
R1 to Present at the Jefferies 2019 Healthcare Conference
28/05/2019
CHICAGO, May 28, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
Autolus Therapeutics to Participate in Upcoming Investor Conferences in June
28/05/2019
LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will [...]
MediPharm Labs Announces $60 Million Bought Deal Equity Financing
28/05/2019
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, May 28, 2019 (GLOBE NEWSWIRE [...]
Genmab Files Registration Statement in the United States for a Proposed Public Offering of American Depositary Shares (ADSs) and Applies for Listing of the ADSs on Nasdaq
28/05/2019
Company Announcement Genmab has today filed a registration statement with the U.S. Securities and Exchange Commission for the proposed public offering of ADSs and has applied for listing of the ADSs on the Nasdaq Global [...]
miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference
28/05/2019
BOULDER, Colo., May 28, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, [...]
MacroGenics to Host Conference Call and Webcast to Review Margetuximab Phase 3 SOPHIA Study Presentation at ASCO
28/05/2019
Rockville, MD, May 28, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Scott Garland, Portola’s president and chief executive officer, will present a corporate [...]
Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
DURHAM, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the [...]
Tonix Pharmaceuticals to Present at BIO 2019 International Convention
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix will present [...]
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
28/05/2019
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory RALEIGH, N.C., May [...]
Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-Cell Receptors Targeting Neoantigens for Cancer with Sleeping Beauty Platform
28/05/2019
– Scope of license includes library of T-cell receptors (TCRs) against neoantigens in hotspots including mutated KRAS, p53 and EGFR for use with Sleeping Beauty platform – – Ziopharm also obtains license to [...]
Rexahn Announces Move to Nasdaq
28/05/2019
Company will trade under the ticker symbol REXN beginning on June 10, 2019 ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company [...]
Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
28/05/2019
CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market
28/05/2019
CHARLOTTESVILLE, Va., May 28, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced the closing of its previously announced registered [...]
Scholar Rock to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors [...]
Evolus to Participate in Three Upcoming Investor Conferences
28/05/2019
NEWPORT BEACH, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that [...]

Pages